Teleflex Incorporated (NYSE:TFX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $264.57.
Several brokerages have recently weighed in on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Royal Bank of Canada raised their price target on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a report on Friday. Stephens upped their price target on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday. Truist Financial lifted their price objective on Teleflex from $235.00 to $240.00 and gave the company a “hold” rating in a research note on Tuesday, July 16th. Finally, Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the company from $205.00 to $245.00 in a report on Monday, July 1st.
Read Our Latest Stock Analysis on Teleflex
Institutional Inflows and Outflows
Teleflex Stock Up 0.5 %
TFX stock opened at $237.13 on Friday. Teleflex has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The stock has a fifty day moving average of $214.14 and a 200-day moving average of $221.29. The company has a market capitalization of $11.17 billion, a price-to-earnings ratio of 38.06, a PEG ratio of 2.26 and a beta of 1.13. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.41 and a current ratio of 2.58.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. During the same period in the previous year, the business earned $3.41 EPS. Teleflex’s revenue was up .9% compared to the same quarter last year. As a group, equities research analysts predict that Teleflex will post 13.88 earnings per share for the current year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Thursday, August 15th will be paid a $0.34 dividend. The ex-dividend date is Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. Teleflex’s dividend payout ratio (DPR) is 21.83%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
- Five stocks we like better than Teleflex
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- Investing in Construction Stocks
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- What Makes a Stock a Good Dividend Stock?
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.